FDA Takes Initial Steps To Quantify Patient Opinion

CDRH survey to quantify patients’ risk tolerance for obesity device therapies will begin soon, but some physicians and patient advocates are urging caution in applying the data.

CDRH is pressing forward with a strategy to quantitatively measure patient opinion and use it to help inform benefit-risk decisions in developing and approving devices. But both physicians and patient groups, while offering general support for the initiative, are warning the device center to proceed cautiously.

The first target for the project is obesity devices, as center officials described at a May 18 meeting at the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation